<?xml version="1.0" encoding="UTF-8"?>
<ref id="BST-49-551C82">
 <label>82</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Mir</surname>, 
    <given-names>R.</given-names>
   </string-name>, 
   <string-name>
    <surname>Tonelli</surname>, 
    <given-names>F.</given-names>
   </string-name>, 
   <string-name>
    <surname>Lis</surname>, 
    <given-names>P.</given-names>
   </string-name>, 
   <string-name>
    <surname>Macartney</surname>, 
    <given-names>T.</given-names>
   </string-name>, 
   <string-name>
    <surname>Polinski</surname>, 
    <given-names>N.K.</given-names>
   </string-name>, 
   <string-name>
    <surname>Martinez</surname>, 
    <given-names>T.N.</given-names>
   </string-name>
   <etal>et al.</etal>
  </person-group> (
  <year>2018</year>) 
  <article-title>The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human</article-title>. 
  <source>Biochem. J.</source>
  <volume>475</volume>, 
  <fpage>1861</fpage>â€“
  <lpage>1883</lpage>
  <pub-id pub-id-type="doi">10.1042/BCJ20180248</pub-id>
  <pub-id pub-id-type="pmid">29743203</pub-id>
 </mixed-citation>
</ref>
